Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2018 Publisher: sanofi-aventis new zealand limited, Level 8, James and Wells Tower, 56 Cawley Street, Ellerslie, Auckland, Telephone: (09) 580 1810
Avomine Tablets 25 mg.
| Pharmaceutical Form |
|---|
|
Tablets, 25 mg (white, scored). |
Promethazine theoclate.
Avomine tablets contain 25 mg of promethazine theoclate.
Excipients with known effect: lactose monohydrate and wheat starch.
For the full list of excipients, see Section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Promethazine |
Promethazine is a potent, long acting, antihistamine with additional anti-emetic central sedative and anti-cholinergic properties. |
| List of Excipients |
|---|
|
Dextrin |
Blister packs containing 10 tablets.
sanofi-aventis new zealand limited, Level 8, James and Wells Tower, 56 Cawley Street, Ellerslie, Auckland, Telephone: (09) 580 1810
Date of first approval: 31 December 1969
| Drug | Countries | |
|---|---|---|
| AVOMINE | Cyprus, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
